Logo image of LXS.DE

LANXESS AG (LXS.DE) Stock Fundamental Analysis

Europe - FRA:LXS - DE0005470405 - Common Stock

21.12 EUR
-0.26 (-1.22%)
Last: 10/6/2025, 7:00:00 PM
Fundamental Rating

3

LXS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 71 industry peers in the Chemicals industry. LXS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. LXS has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

LXS had positive earnings in the past year.
In the past year LXS had a positive cash flow from operations.
LXS had positive earnings in 4 of the past 5 years.
In the past 5 years LXS always reported a positive cash flow from operatings.
LXS.DE Yearly Net Income VS EBIT VS OCF VS FCFLXS.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

1.2 Ratios

The Return On Assets of LXS (-1.96%) is worse than 67.61% of its industry peers.
LXS has a worse Return On Equity (-4.13%) than 66.20% of its industry peers.
Industry RankSector Rank
ROA -1.96%
ROE -4.13%
ROIC N/A
ROA(3y)1.66%
ROA(5y)3.5%
ROE(3y)3.89%
ROE(5y)9.65%
ROIC(3y)N/A
ROIC(5y)N/A
LXS.DE Yearly ROA, ROE, ROICLXS.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

LXS's Operating Margin has declined in the last couple of years.
LXS's Gross Margin of 21.19% is on the low side compared to the rest of the industry. LXS is outperformed by 67.61% of its industry peers.
LXS's Gross Margin has declined in the last couple of years.
LXS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 21.19%
OM growth 3Y-49.18%
OM growth 5Y-37.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.56%
GM growth 5Y-4.64%
LXS.DE Yearly Profit, Operating, Gross MarginsLXS.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

4

2. Health

2.1 Basic Checks

LXS does not have a ROIC to compare to the WACC, probably because it is not profitable.
LXS has about the same amout of shares outstanding than it did 1 year ago.
LXS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, LXS has an improved debt to assets ratio.
LXS.DE Yearly Shares OutstandingLXS.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
LXS.DE Yearly Total Debt VS Total AssetsLXS.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

An Altman-Z score of 1.94 indicates that LXS is not a great score, but indicates only limited risk for bankruptcy at the moment.
LXS's Altman-Z score of 1.94 is in line compared to the rest of the industry. LXS outperforms 42.25% of its industry peers.
The Debt to FCF ratio of LXS is 22.23, which is on the high side as it means it would take LXS, 22.23 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of LXS (22.23) is comparable to the rest of the industry.
LXS has a Debt/Equity ratio of 0.60. This is a neutral value indicating LXS is somewhat dependend on debt financing.
LXS's Debt to Equity ratio of 0.60 is on the low side compared to the rest of the industry. LXS is outperformed by 60.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 22.23
Altman-Z 1.94
ROIC/WACCN/A
WACC4.68%
LXS.DE Yearly LT Debt VS Equity VS FCFLXS.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 2.41 indicates that LXS has no problem at all paying its short term obligations.
LXS has a better Current ratio (2.41) than 77.46% of its industry peers.
LXS has a Quick Ratio of 1.24. This is a normal value and indicates that LXS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.24, LXS is in the better half of the industry, outperforming 60.56% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.41
Quick Ratio 1.24
LXS.DE Yearly Current Assets VS Current LiabilitesLXS.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

4

3. Growth

3.1 Past

LXS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 244.27%, which is quite impressive.
Measured over the past years, LXS shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -19.38% on average per year.
The Revenue has decreased by -2.75% in the past year.
LXS shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.32% yearly.
EPS 1Y (TTM)244.27%
EPS 3Y-31.1%
EPS 5Y-19.38%
EPS Q2Q%-1.67%
Revenue 1Y (TTM)-2.75%
Revenue growth 3Y1.43%
Revenue growth 5Y-1.32%
Sales Q2Q%-12.63%

3.2 Future

LXS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.66% yearly.
The Revenue is expected to grow by 0.37% on average over the next years.
EPS Next Y-89.73%
EPS Next 2Y-8.58%
EPS Next 3Y7.61%
EPS Next 5Y17.66%
Revenue Next Year-7.68%
Revenue Next 2Y-3.31%
Revenue Next 3Y-1.11%
Revenue Next 5Y0.37%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LXS.DE Yearly Revenue VS EstimatesLXS.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B
LXS.DE Yearly EPS VS EstimatesLXS.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 11.17, which indicates a very decent valuation of LXS.
LXS's Price/Earnings ratio is rather cheap when compared to the industry. LXS is cheaper than 90.14% of the companies in the same industry.
LXS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.90.
Based on the Price/Forward Earnings ratio of 16.00, the valuation of LXS can be described as correct.
66.20% of the companies in the same industry are more expensive than LXS, based on the Price/Forward Earnings ratio.
LXS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.36.
Industry RankSector Rank
PE 11.17
Fwd PE 16
LXS.DE Price Earnings VS Forward Price EarningsLXS.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

LXS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. LXS is cheaper than 83.10% of the companies in the same industry.
78.87% of the companies in the same industry are more expensive than LXS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.28
EV/EBITDA 5.97
LXS.DE Per share dataLXS.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.58%
EPS Next 3Y7.61%

0

5. Dividend

5.1 Amount

LXS has a yearly dividend return of 0.47%, which is pretty low.
The stock price of LXS dropped by -20.24% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
LXS's Dividend Yield is slightly below the industry average, which is at 3.05.
Compared to an average S&P500 Dividend Yield of 2.44, LXS's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.47%

5.2 History

The dividend of LXS decreases each year by -35.08%.
Dividend Growth(5Y)-35.08%
Div Incr Years0
Div Non Decr Years1
LXS.DE Yearly Dividends per shareLXS.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

LXS has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-6.06%
EPS Next 2Y-8.58%
EPS Next 3Y7.61%
LXS.DE Yearly Income VS Free CF VS DividendLXS.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M

LANXESS AG

FRA:LXS (10/6/2025, 7:00:00 PM)

21.12

-0.26 (-1.22%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-06 2025-11-06
Inst Owners62.26%
Inst Owner ChangeN/A
Ins Owners2.86%
Ins Owner ChangeN/A
Market Cap1.82B
Analysts55.56
Price Target26.34 (24.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.47%
Yearly Dividend0.1
Dividend Growth(5Y)-35.08%
DP-6.06%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)342.83%
Min EPS beat(2)179.44%
Max EPS beat(2)506.23%
EPS beat(4)4
Avg EPS beat(4)291.96%
Min EPS beat(4)130.13%
Max EPS beat(4)506.23%
EPS beat(8)7
Avg EPS beat(8)214.49%
EPS beat(12)11
Avg EPS beat(12)158.11%
EPS beat(16)14
Avg EPS beat(16)122.5%
Revenue beat(2)0
Avg Revenue beat(2)-5.13%
Min Revenue beat(2)-8.49%
Max Revenue beat(2)-1.78%
Revenue beat(4)0
Avg Revenue beat(4)-4.88%
Min Revenue beat(4)-8.49%
Max Revenue beat(4)-1.78%
Revenue beat(8)1
Avg Revenue beat(8)-5.19%
Revenue beat(12)3
Avg Revenue beat(12)-2.77%
Revenue beat(16)3
Avg Revenue beat(16)-5.61%
PT rev (1m)-6.23%
PT rev (3m)-10.26%
EPS NQ rev (1m)-34.47%
EPS NQ rev (3m)-103.5%
EPS NY rev (1m)15.71%
EPS NY rev (3m)-89.99%
Revenue NQ rev (1m)-1.73%
Revenue NQ rev (3m)-4.02%
Revenue NY rev (1m)-2.98%
Revenue NY rev (3m)-6.37%
Valuation
Industry RankSector Rank
PE 11.17
Fwd PE 16
P/S 0.3
P/FCF 16.28
P/OCF 4.14
P/B 0.46
P/tB 1.05
EV/EBITDA 5.97
EPS(TTM)1.89
EY8.95%
EPS(NY)1.32
Fwd EY6.25%
FCF(TTM)1.3
FCFY6.14%
OCF(TTM)5.11
OCFY24.18%
SpS71.2
BVpS46.22
TBVpS20.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.96%
ROE -4.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 21.19%
FCFM 1.82%
ROA(3y)1.66%
ROA(5y)3.5%
ROE(3y)3.89%
ROE(5y)9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-49.18%
OM growth 5Y-37.41%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.56%
GM growth 5Y-4.64%
F-Score6
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 22.23
Debt/EBITDA 4.11
Cap/Depr 51.65%
Cap/Sales 5.35%
Interest Coverage N/A
Cash Conversion 75.26%
Profit Quality N/A
Current Ratio 2.41
Quick Ratio 1.24
Altman-Z 1.94
F-Score6
WACC4.68%
ROIC/WACCN/A
Cap/Depr(3y)54.6%
Cap/Depr(5y)69.53%
Cap/Sales(3y)4.97%
Cap/Sales(5y)6.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)244.27%
EPS 3Y-31.1%
EPS 5Y-19.38%
EPS Q2Q%-1.67%
EPS Next Y-89.73%
EPS Next 2Y-8.58%
EPS Next 3Y7.61%
EPS Next 5Y17.66%
Revenue 1Y (TTM)-2.75%
Revenue growth 3Y1.43%
Revenue growth 5Y-1.32%
Sales Q2Q%-12.63%
Revenue Next Year-7.68%
Revenue Next 2Y-3.31%
Revenue Next 3Y-1.11%
Revenue Next 5Y0.37%
EBIT growth 1Y92.44%
EBIT growth 3Y-48.45%
EBIT growth 5Y-38.23%
EBIT Next Year1115.36%
EBIT Next 3Y148.95%
EBIT Next 5Y77.75%
FCF growth 1Y250%
FCF growth 3YN/A
FCF growth 5Y6.85%
OCF growth 1Y6.52%
OCF growth 3Y7.67%
OCF growth 5Y-4.6%